Next |
home / stock / vygr / vygr message board
Subject | By | Source | When |
---|---|---|---|
$VYGR bulls and bears | Argus63 | investorshub | 05/08/2023 7:35:34 PM |
$VYGR The now last trade up | Gary Ray | investorshub | 05/08/2023 12:07:45 PM |
$VYGR bears are running | Gator44 | investorshub | 05/08/2023 9:46:10 AM |
MomentumIts now | Gary Ray | investorshub | 05/08/2023 4:34:43 AM |
$VYGR The trading last up | Argus63 | investorshub | 05/08/2023 1:48:09 AM |
Price trading up | ttottip | investorshub | 05/07/2023 5:34:05 PM |
Time for a bounce? | ttottip | investorshub | 05/06/2023 2:50:18 PM |
MomentumIts trading last trade up | Gator44 | investorshub | 05/06/2023 1:20:21 PM |
$VYGR bears and bulls | TheFinalCD | investorshub | 05/06/2023 4:03:23 AM |
here we go bulls news is here | Gary Ray | investorshub | 05/05/2023 8:00:23 AM |
What do you make of this? | Gary Ray | investorshub | 05/04/2023 11:29:20 PM |
$VYGR is it bear time? Or do we go bull? | Argus63 | investorshub | 05/04/2023 10:22:18 PM |
Have a look at this | TheFinalCD | investorshub | 05/04/2023 1:15:31 PM |
$VYGR news all the way baby | Elgordo84 | investorshub | 05/04/2023 9:14:27 AM |
$VYGR MomentumIts gaining up | Gator44 | investorshub | 05/03/2023 1:46:56 PM |
Price now last trade up | Roadtojourney | investorshub | 05/02/2023 8:49:23 PM |
MomentumIts gaining last up | Gary Ray | investorshub | 05/01/2023 6:00:14 PM |
Price trading up | Elgordo84 | investorshub | 04/30/2023 1:16:36 PM |
The now | Gary Ray | investorshub | 04/29/2023 6:42:00 PM |
Time for a bounce? | Argus63 | investorshub | 04/29/2023 9:29:16 AM |
News, Short Squeeze, Breakout and More Instantly...
Voyager Therapeutics Inc. Company Name:
VYGR Stock Symbol:
NASDAQ Market:
Voyager Therapeutics Inc. Website:
- Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in 2026 - - VY1706 is the fifth neuro gene therapy development candidate nominated leveraging Voyager’s IV-delivered, CNS-penetrant TRACER capsids - LE...
- Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer’s; on track to generate top-line data H1 2025 - - Recent third-party clinical data establish that an antibody can inhibit tau accumulation in the human brain; provide ...
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report third quarter 2024 financial and operating results after market close on Tuesday, November...